Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial "POINT"

Recruiting

Phase 3 Results N/A

Summary of Purpose

A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction. An ischemic stroke is a cerebral infarction. In POINT, eligibility is limited to brain TIAs and to minor ischemic strokes (with an NIH Stroke Scale [NIHSS] score less than or equal to 3). TIAs are common [25], and are often harbingers of disabling...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 August 2017.

1 Oct 2009 6 Oct 2009 1 Jun 2018 1 Dec 2018 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts